Abstract
Penile cancer is an uncommon disease in the industrialized world that most frequently presents at low stage and is cured with treatment of local and regional surgery. In cases of advanced cancer, the use of more aggressive surgical techniques and the addition of adjuvant therapy may be warranted. So far, few agents have been found that improve survival with metastatic disease and thus aggressive primary treatment is required. This review discusses diagnosis, staging, and therapy for high risk penile cancer.
Similar content being viewed by others
References
Pow-Sang MR et al (2010) Epidemiology and natural history of penile cancer. Urology 76(2 Suppl 1):S2–S6
Soria JC et al (1997) Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in a monocentric study with a conservative policy. Ann Oncol 8(11):1089–1098
Tseng HF et al (2001) Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (US). Cancer Causes Control 12(3):267–277
Maden C et al (1993) History of circumcision, medical conditions, and sexual-activity and risk of penile cancer. J Natl Cancer Inst 85(1):19–24
Harish K, Ravi R (1995) The role of tobacco in penile carcinoma. Br J Urol 75(3):375–377
Hungerhuber E et al (2006) Risk stratification in penile carcinoma: 25-year experience with surgical inguinal lymph node staging. Urology 68(3):621–625
Antunes AA, Dall’Oglio MF, Srougi M (2007) Organ-sparing treatment for penile cancer. Nat Clin Pract Urol 4(11):596–604
Hardner GJ et al (1972) Carcinoma of the penis: analysis of therapy in 100 consecutive cases. J Urol 108(3):428–430
Lont AP et al (2007) Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J Urol 177(3):947–952
Pizzocaro G et al (2010) EAU penile cancer guidelines 2009. Eur Urol 57(6):1002–1012
Haas GP et al (1999) Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a southwest oncology group study. J Urol 161(6):1823–1825
Srinivas V et al (1987) Penile cancer: relation of extent of nodal metastasis to survival. J Urol 137(5):880–882
Ravi R (1993) Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol 72(5 Pt 2):817–819
Ornellas AA et al (1994) Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol 151(5):1244–1249
Scardino E et al (2004) Magnetic resonance imaging combined with artificial erection for local staging of penile cancer. Urology 63(6):1158–1162
Hughes B et al (2009) Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer. World J Urol 27(2):197–203
Scher B et al (2005) 18F-FDG PET/CT for staging of penile cancer. J Nucl Med 46(9):1460–1465
Schlenker B et al (2009) Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: a prospective single-center study. Urol Oncol 30(9):753–769
Graafland NM et al (2010) 18F-FDG PET/CT for monitoring induction chemotherapy in patients with primary inoperable penile carcinoma: first clinical results. Eur J Nucl Med Mol Imaging 37(8):1474–1480
Esen G (2006) Ultrasound of superficial lymph nodes. Eur J Radiol 58(3):345–359
Tabatabaei S, Harisinghani M, McDougal WS (2005) Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer. J Urol 174(3):923–927 discussion 927
D’Ancona CA et al (1997) Quality of life after partial penectomy for penile carcinoma. Urology 50(4):593–596
Horenblas S, van Tinteren H (1994) Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. J Urol 151(5):1239–1243
Davis JW, Schellhammer PF, Schlossberg SM (1999) Conservative surgical therapy for penile and urethral carcinoma. Urology 53(2):386–392
Solsona E et al (2001) Prospective validation of association of local tumor stage and grade as predictive factor for occult lymph node micrometastases in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol 165(5):1506–1509
Hegarty PK et al (2006) A prospective study of 100 cases of penile cancer managed according to European association of urology guidelines. BJU Int 98(3):526–531
Thuret R et al (2010) A contemporary population-based assessment of the rate of lymph node dissection for penile carcinoma. Ann Surg Oncol 18(2):439–446
Cabanas RM (1992) Anatomy and biopsy of sentinel lymph nodes. Urol Clin North Am 19(2):267–276
Pettaway CA et al (1995) Sentinel lymph-node dissection for penile carcinoma: the M-D-Anderson-cancer-center experience. J Urol 154(6):1999–2003
Tanis PJ et al (2002) Dynamic sentinel node biopsy for penile cancer: reliability of a staging technique. J Urol 168(1):76–80
Spiess PE, Hernandez MS, Pettaway CA (2009) Contemporary inguinal lymph node dissection: minimizing complications. World J Urol 27(2):205–212
Hughes BE et al (2010) Lymph node metastasis in intermediate-risk penile squamous cell cancer: a two-centre experience. Eur Urol 57(4):688–692
Sanchez-Ortiz RF, Pettaway CA (2004) The role of lymphadenectomy in penile cancer. Urol Oncol 22(3):236–244 discussion 244–245
Daseler EH, Anson BJ, Reimann AF (1948) Radical excision of the inguinal and iliac lymph glands: a study based upon 450 anatomical dissections and upon supportive clinical observations. Surg Gynecol Obstet 87(6):679–694
Evriviades D, Raurell A, Perks AG (2007) Pedicled anterolateral thigh flap for reconstruction after radical groin dissection. Urology 70(5):996–999
Bermejo C et al (2007) Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 177(4):1335–1338
Assimos DG, Jarow JP (1994) Role of laparoscopic pelvic lymph node dissection in the management of patients with penile cancer and inguinal adenopathy. J Endourol 8(5):365–369
Mahlmann B, Doehn C, Feyerabend T (2001) Radiotherapy of penile cancer. Urol A 40(4):308
de Crevoisier R et al (2009) Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N− or NX). Int J Radiat Oncol Biol Phys 74(4):1150–1156
Crook J, Ma C, Grimard L (2009) Radiation therapy in the management of the primary penile tumor: an update. World J Urol 27(2):189–196
Crook J, Jezioranski J, Cygler JE (2010) Penile brachytherapy: technical aspects and post implant issues. Brachytherapy 9(2):151–158
Crook JM et al (2005) Penile brachytherapy: results for 49 patients. Int J Radiat Oncol Biol Phys 62(2):460–467
Murrell DS, Williams JL (1965) Radiotherapy in the treatment of carcinoma of the penis. Br J Urol 37:211–222
Edsmyr F, Andersson L, Esposti PL (1985) Combined bleomycin and radiation therapy in carcinoma of the penis. Cancer 56(6):1257–1263
Ahmed T, Sklaroff R, Yagoda A (1984) An appraisal of the efficacy of bleomycin in epidermoid carcinoma of the penis. Anticancer Res 4(4–5):289–292
Ahmed T, Sklaroff R, Yagoda A (1984) Sequential trials of methotrexate, cisplatin and bleomycin for penile cancer. J Urol 132(3):465–468
Hussein AM, Benedetto P, Sridhar KS (1990) Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 65(3):433–438
Dexeus FH et al (1991) Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract. J Urol 146(5):1284–1287
Hakenberg OW et al (2006) Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma. BJU Int 98(6):1225–1227
Pizzocaro G, Piva L (1998) Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 27(6b):823–824
Theodore C et al (2008) A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992). Ann Oncol 19(7):1304–1307
Pagliaro LC et al (2010) Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol 28(24):3851–3857
Modig H, Duchek M, Sjodin JG (1993) Carcinoma of the penis. Treatment by surgery or combined bleomycin and radiation therapy. Acta Oncol 32(6):653–655
Gotsadze D et al (2000) Is conservative organ-sparing treatment of penile carcinoma justified? Eur Urol 38(3):306–312
Perez-Tamayot C (1987) Combined approach to squamous cell carcinoma of the penis (SCP). Proc Am Soc Clin Oncol 6:109
Clavel M et al (1994) Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC head and neck cancer cooperative group. Ann Oncol 5(6):521–526
Leijte JA et al (2007) Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol 52(2):488–494
Edge SB, Byrd DR, Compton CC et al (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, NY, p 449
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heinlen, J.E., Buethe, D.D. & Culkin, D.J. Advanced penile cancer. Int Urol Nephrol 44, 139–148 (2012). https://doi.org/10.1007/s11255-011-0011-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-011-0011-1